Curtiss Frederic R, Fry Richard N, Avey Steven G
J Manag Care Pharm. 2004 Jan-Feb;10(1):60-78. doi: 10.18553/jmcp.2004.10.1.60.
To review the literature on the subject of quality improvement principles and methods applied to pharmacy services and to describe a framework for current and future efforts in pharmacy services quality improvement and effective drug therapy management.
The Academy of Managed Care Pharmacy produced the Catalog of Pharmacy Quality Indicators in 1997, followed by the Summary of National Pharmacy Quality Measures in February 1999. In April 2002, AMCP introduced Pharmacy's Framework for Drug Therapy Management in the 21st Century. The Framework documents include a self-assessment tool that details more than 250 specific "components" that describe tasks, behaviors, skills, functions, duties, and responsibilities that contribute to meeting customer expectations for effective drug therapy management.
There are many opportunities for quality improvement in clinical, service, and cost outcomes related to drug therapy management. These may include patient safety; incidence of medical errors; adverse drug events; patient adherence to therapy; attainment of target goals of blood pressure, glucose, and lipid levels; risk reduction for adverse cardiac events and osteoporotic-related fractures; patient satisfaction; risk of hospitalization or mortality; and cost of care. Health care practitioners can measure improvements in health care quality in several ways including (a) a better patient outcome at the same cost, (b) the same patient outcome at lower cost, (c) a better patient outcome at lower cost, or (d) a significantly better patient outcome at moderately higher cost. Measurement makes effective management possible. A framework of component factors (e.g., tasks) is necessary to facilitate changes in the key processes and critical factors that will help individual practitioners and health care systems meet customer expectations in regard to drug therapy, thus improving these outcomes.
Quality improvement in health care services in the United States will be made in incremental changes that rely on a structure-process-outcome model. The structure is provided by evidence created from controlled randomized trials and other studies of care and system outcomes that are based on the scientific method. The process portion is created by the application of evidence in the form of clinical practice guidelines, clinical practice models, and self-assessment tools such as Pharmacy's Framework for Drug Therapy Management. Incremental changes in structure and process will result in the desirable outcome of meeting customer needs for more effective drug therapy and disease management.
回顾关于应用于药学服务的质量改进原则和方法的文献,并描述当前及未来药学服务质量改进和有效药物治疗管理工作的框架。
管理式医疗药学学会于1997年编制了《药学质量指标目录》,随后于1999年2月发布了《国家药学质量指标摘要》。2002年4月,AMCP推出了《21世纪药学药物治疗管理框架》。该框架文件包括一个自我评估工具,详细列出了250多个具体的“组成部分”,这些部分描述了有助于满足客户对有效药物治疗管理期望的任务、行为、技能、功能、职责和责任。
在与药物治疗管理相关的临床、服务和成本结果方面,存在许多质量改进的机会。这些机会可能包括患者安全;医疗差错发生率;药物不良事件;患者对治疗的依从性;血压、血糖和血脂水平目标的达成情况;降低心脏不良事件和骨质疏松相关骨折的风险;患者满意度;住院或死亡风险;以及护理成本。医疗保健从业者可以通过多种方式衡量医疗保健质量的改进,包括:(a)以相同成本获得更好的患者结果;(b)以更低成本获得相同的患者结果;(c)以更低成本获得更好的患者结果;或(d)以适度更高的成本获得显著更好的患者结果。测量使有效管理成为可能。一个由组成因素(如任务)构成的框架对于促进关键流程和关键因素的改变是必要的,这些改变将帮助个体从业者和医疗保健系统在药物治疗方面满足客户期望,从而改善这些结果。
美国医疗保健服务的质量改进将通过依赖结构-过程-结果模型的渐进式变革来实现。结构由基于科学方法的对照随机试验和其他护理及系统结果研究产生的证据提供。过程部分通过以临床实践指南、临床实践模型和自我评估工具(如《药学药物治疗管理框架》)形式应用证据来创建。结构和过程的渐进式变革将带来满足客户对更有效药物治疗和疾病管理需求的理想结果。